BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 30035710)

  • 21. Prevalence, incidence and risk factors for acquisition and colonization of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae from dogs attended at a veterinary hospital in Spain.
    Ortiz-Díez G; Mengíbar RL; Turrientes MC; Artigao MB; Gallifa RL; Tello AM; Pérez CF; Santiago TA
    Comp Immunol Microbiol Infect Dis; 2023 Jan; 92():101922. PubMed ID: 36509030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.
    Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and prevalence of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in humans, animals and the environment in West and Central Africa.
    Ouchar Mahamat O; Kempf M; Lounnas M; Tidjani A; Hide M; Benavides JA; Carrière C; Bañuls AL; Jean-Pierre H; Ouedraogo AS; Dumont Y; Godreuil S
    Int J Antimicrob Agents; 2021 Jan; 57(1):106203. PubMed ID: 33075511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbapenemase-producing Enterobacteriaceae: a 2-year surveillance in a hospital in Iaşi, Romania.
    Braun SD; Dorneanu OS; Vremeră T; Reißig A; Monecke S; Ehricht R
    Future Microbiol; 2016; 11(3):391-401. PubMed ID: 26974389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.
    Kantele A; Lääveri T; Mero S; Vilkman K; Pakkanen SH; Ollgren J; Antikainen J; Kirveskari J
    Clin Infect Dis; 2015 Mar; 60(6):837-46. PubMed ID: 25613287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended-spectrum beta-lactamase (ESBL)- and carbapenemase-producing Enterobacteriaceae in water sources in Lebanon.
    Diab M; Hamze M; Bonnet R; Saras E; Madec JY; Haenni M
    Vet Microbiol; 2018 Apr; 217():97-103. PubMed ID: 29615264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
    Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.
    Iacchini S; Sabbatucci M; Gagliotti C; Rossolini GM; Moro ML; Iannazzo S; D'Ancona F; Pezzotti P; Pantosti A
    Euro Surveill; 2019 Jan; 24(5):. PubMed ID: 30722813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.
    Velasco JM; Valderama MT; Peacock T; Warawadee N; Nogrado K; Navarro FC; Chua D; Apichai S; Sirigade R; Macareo LR; Swierczewski B
    Emerg Infect Dis; 2017 Sep; 23(9):1597-1598. PubMed ID: 28820383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco.
    Girlich D; Bouihat N; Poirel L; Benouda A; Nordmann P
    Clin Microbiol Infect; 2014 Apr; 20(4):350-4. PubMed ID: 23927757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in HIV-infected children in Zimbabwe.
    Wilmore SMS; Kranzer K; Williams A; Makamure B; Nhidza AF; Mayini J; Bandason T; Metcalfe J; Nicol MP; Balakrishnan I; Ellington MJ; Woodford N; Hopkins S; McHugh TD; Ferrand RA
    J Med Microbiol; 2017 May; 66(5):609-615. PubMed ID: 28513417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Tal Jasper R; Coyle JR; Katz DE; Marchaim D
    Future Microbiol; 2015; 10(5):819-39. PubMed ID: 26000652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
    Hayakawa K; Nakano R; Hase R; Shimatani M; Kato H; Hasumi J; Doi A; Sekiya N; Nei T; Okinaka K; Kasahara K; Kurai H; Nagashima M; Miyoshi-Akiyama T; Kakuta R; Yano H; Ohmagari N
    J Antimicrob Chemother; 2020 Mar; 75(3):697-708. PubMed ID: 31789374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relating knowledge, attitude and practice of antibiotic use to extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage: results of a cross-sectional community survey.
    Mo Y; Seah I; Lye PSP; Kee XLJ; Wong KYM; Ko KKK; Ong RT; Tambyah PA; Cook AR
    BMJ Open; 2019 Mar; 9(3):e023859. PubMed ID: 30842108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct β-Lactam Inactivation Method: a New Low-Cost Assay for Rapid Detection of Carbapenemase- or Extended-Spectrum-β-Lactamase-Producing
    Bianco G; Boattini M; Iannaccone M; Fossati L; Cavallo R; Costa C
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31694972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Level Carbapenem Resistance in OXA-232-Producing Raoultella ornithinolytica Triggered by Ertapenem Therapy.
    Iovleva A; Mettus RT; McElheny CL; Griffith MP; Mustapha MM; Pasculle AW; Shields RK; Cooper VS; Doi Y
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacterales in Children, United States, 2016-2020.
    Grome HN; Grass JE; Duffy N; Bulens SN; Ansari U; Campbell D; Lutgring JD; Gargis AS; Masters T; Kent AG; McKay SL; Smith G; Wilson LE; Vaeth E; Evenson B; Dumyati G; Tsay R; Phipps E; Flores K; Wilson CD; Czaja CA; Johnston H; Janelle SJ; Lynfield R; O'Malley S; Vagnone PS; Maloney M; Nadle J; Guh AY
    Emerg Infect Dis; 2024 Jun; 30(6):1104-1114. PubMed ID: 38781979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
    Dortet L; Poirel L; Al Yaqoubi F; Nordmann P
    Clin Microbiol Infect; 2012 May; 18(5):E144-8. PubMed ID: 22404169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
    Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
    Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.